Digital Health Startups

Endobits is clinical decision-support software that runs on top of FDA-cleared continuous glucose monitors to help qualified healthcare professionals and clinics manage glucose-related conditions such as dysglycemia and pre-diabetes. The software supports clinician-directed care and references CPT codes for billing, while providers retain full clinical authority.

1 investor

Bioelectrix develops patented wound electrodes that deliver gentle direct current to reactivate stalled healing while capturing real-time healing data, aiming to accelerate closure of hard-to-heal wounds. Its bioelectronic wound therapy initially targets diabetic foot ulcers and is intended for clinicians, payers, and existing healthcare wound care workflows.

1 investor

Biofourmis provides technology-enabled solutions and a platform for AI-driven in-home patient care, using wearable biosensors and remote monitoring to deliver and transition patients across levels of care. It serves healthcare providers and partners, aiming to reduce hospital readmissions and cost of care.

1 investor

Biogazelle provides genomic and transcriptomic laboratory services from ISO17025-accredited and GCLP-compliant labs, supporting research, diagnostics, therapeutics, and clinical trials. It serves scientists and clinicians working in personalized medicine.

1 investor

Tenzr Health provides a patient engagement and monitoring platform for physical and occupational therapy recovery. The platform enables care teams to track patient progress outside scheduled visits through guided exercises, education, and symptom tracking while capturing continuous recovery data.

1 investor

1 investor

Groupe Biolam operates a network of medical biology laboratories that provide diagnostic analyses and support patients in their care pathway. It runs 28 labs in Hauts-de-France, 13 in Normandy, and 10 in Île-de-France.

1 investor

Biomakers operates a precision oncology platform that combines genomic testing, clinical data, biobanking, and AI to support cancer care and drug and diagnostic development. It focuses on expanding access to cancer care across Latin America while generating clinical and biospecimen data.

1 investor

Biomarq Health develops a wearable, injectable multi-analyte biosensor platform that continuously monitors biochemical markers such as glucose, lactate, ketones, cortisol, and kidney-related analytes from a single sensor. Its first product targets affordable continuous glucose monitoring for people with type 1, type 2, and pre-diabetes, with planned applications in chronic kidney disease, pregnancy monitoring, and healthspan research.

1 investor

Biomarx develops automated liquid biopsy diagnostics using biosensing technologies for early cancer and disease detection, delivering test results in under two hours at low cost. Its products target clinicians and healthcare providers seeking rapid, affordable precision diagnostics for personalised medicine.

1 investor

Biome Resources is a microbiome company that develops products including Kronobiotic, a precision probiotic aimed at improving sleep quality, and Biome360, a gut microbiome analysis kit for personalized nutrition and preventive health. It combines biochemists, data scientists, and engineers to offer microbiome testing and preventive health technology at accessible cost.

1 investor

bioMérieux develops in vitro diagnostic solutions for clinical laboratories and healthcare professionals, covering areas such as antimicrobial stewardship, sepsis, and infectious disease detection. It also provides diagnostics for food safety and quality and pharmaceutical quality control.

1 investor

Biomine Health is South Africa's microbiome testing and treatment company, providing personalized health insights based on microbiome analysis to help people understand and optimize their gut health. The company serves individuals seeking proactive health management through microbiome-based diagnostics and treatments.

1 investor

Bioness Medical develops rehabilitation medical technologies—including functional electrical stimulation systems, robotic body-weight support, upper-extremity exoskeletons, and a software-based therapy platform—for people recovering from stroke, brain injury, MS, and other conditions, and for the clinicians who treat them. The company also offers a virtual training platform for clinicians in neurorehabilitation.

1 investor

BioPharm Communications operates an always-on marketing network reaching over 3 million healthcare decision makers, offering multichannel advertising, trigger-based engagement, and KOL-led educational content for pharmaceutical and healthcare brands. It provides targeted campaign activation, medical journal partnerships, and measurement tools to help brands reach and educate HCPs.

1 investor

BioRestore is a healthcare clinic offering age-related and wellness treatments, including hormone/regenerative therapies and non-invasive pain treatments such as Bio Wave therapy, delivered by clinicians like nurse practitioners and physicians. It serves individual patients seeking evidence-based, patient-centric care, with a presence in New England.

1 investor

BioSens8 develops a platform that identifies microbes to engineer biosensors for quantitative, real-time, and continuous monitoring. The company is expanding its biosensor technology beyond glucose monitoring.

1 investor

Biosense Technologies develops user-friendly medical devices for basic screening tests, aimed at reducing the load on primary healthcare services and enabling users to screen and manage conditions in real time. Its focus areas include diseases such as diabetes, heart disease, and cancer.

1 investor

Biospectal develops OptiBP, a smartphone app that measures and tracks blood pressure using a fingertip on the phone's camera, allowing users to record BP history and share it with doctors. The app is CE-MDR EU Class IIa certified and targets people managing hypertension and heart health.

1 investor

BioticsAI develops AI-powered computer vision solutions for fetal anatomy screening and maternal ultrasound diagnostics. The company serves healthcare providers and maternal-fetal medicine specialists seeking to standardize and improve the accuracy of prenatal ultrasound assessments.

1 investor

Biotronics3D provides a cloud-based, zero-footprint medical imaging platform with RIS and PACS functionality, teleradiology modules, and AI-assisted diagnostic tools for hospitals, clinics, imaging centers, and teleradiology providers. The platform supports image routing, reporting, and workflow management, and is used across more than 400 sites in Europe.

1 investor

BiteLabs operates an AI and digital health fellowship programme that trains clinicians and non-clinicians for careers in healthtech. The organization provides education in clinical product management, healthcare AI, and health regulation, serving professionals seeking to transition into digital health roles.

1 investor

Bitgenia offers DNA testing from a saliva sample to provide insights on health, nutrition, and sports, and develops a bioinformatics platform for large-scale genomic data processing. It serves hospitals, clinics, laboratories, and pharmaceutical companies looking to apply genomics.

1 investor

BlackDoctor.com is a health information and media website publishing health news and wellness articles with a focus on the African American community.

1 investor